Bosulif
List of products in the National Drug Code with proprietary name bosulif. Bosutinib is used to treat a certain type of blood cancer (chronic myelogenous leukemia-CML). It works by slowing or stopping the growth of cancer cells.
| NDC | Proprietary Name | Non-Proprietary Name | Dosage Form | Route Name | Labeler Name | Product Type |
|---|---|---|---|---|---|---|
| 0069-0135 | Bosulif | Bosutinib | Tablet, Film Coated | Oral | Pfizer Laboratories Div Pfizer Inc | Human Prescription Drug |
| 0069-0136 | Bosulif | Bosutinib | Tablet, Film Coated | Oral | Pfizer Laboratories Div Pfizer Inc | Human Prescription Drug |
| 0069-0193 | Bosulif | Bosutinib | Tablet, Film Coated | Oral | Pfizer Laboratories Div Pfizer Inc | Human Prescription Drug |
| 0069-0504 | Bosulif | Bosutinib | Capsule | Oral | Pfizer Laboratories Div Pfizer Inc | Human Prescription Drug |
| 0069-1014 | Bosulif | Bosutinib | Capsule | Oral | Pfizer Laboratories Div Pfizer Inc | Human Prescription Drug |
| 63539-193 | Bosulif | Bosutinib | Tablet, Film Coated | Oral | U.s. Pharmaceuticals | Human Prescription Drug |
| 63539-117 | Bosulif | U.s. Pharmaceuticals |
